Thursday, November 22, 2018

Resveratrol-based Nutraceuticals for the Management of Diabetes and Obesity: Real Therapeutic Potential or a mere Palliative?: (ADO)- Lupine Publishers



It is well known that obesity and diabetes (more specifically, the type 2 diabetes mellitus, T2DM) are currently a growing public health problem, which involves several millions subjects in the World. Years ago, indeed, the term “diabesity” was coined highlighting not only the strong pathogenic relationship between obesity and T2DM, but also the pandemic aspect that link these two diseases. The increasing global prevalence of diabesity represents a grave concern in terms of public health and, at the same time, medical costs, resulting in a serious social economic issue.


For more lupine publishers Open Access Journals please visit our website
For more Diabetes Obesity Open access Journal articles please click here

No comments:

Post a Comment

Lupine Publishers| Semaglutide versus liraglutide for treatment of obesity

  Lupine Publishers| Journal of Diabetes and Obesity Abstract Background: Once weekly (OW) semaglutide is a glucagon-like peptide...